Pune, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Antibody Production Market Analysis:
“According to SNS Insider Research, The Antibody Production Market size was estimated at USD 14.33 billion in 2023 and is expected to reach USD 36.49 billion by 2032 with a growing CAGR of 10.95% during the forecast period of 2024-2032.”
Rising Need for Targeted Therapies & Advancements in Technologies to Drive the Antibody Production Market Forward
The increasing demand for targeted therapies and the continuous technological advancements are two of the major factors behind the rapid growth of the antibody production market. Indeed, targeted therapies, based on specific molecular targets of diseases, are featuring as the support of contemporary treatment policies. This kind of therapy is related to higher efficacy with reduced side effects than conventional treatment modalities, hence increasing the demand for quality antibodies.
Parallel to this, the advances in biotechnology—recombinant DNA technology, monoclonal antibody production, and high-throughput screening methods are making a major change in how the antibodies will be produced in the near future. Improving technology serves to increase the accuracy, yield, and cost-effectiveness of the antibody production process and shall further enable new and improved therapeutic antibodies. Thus, the antibody production market is expected to propel expansion in coming years. With further research and development, the industry has bright prospects of growth due to new advancements in technology and rising therapeutic needs.
Get a Sample Report of Antibody Production Market@ https://www.snsinsider.com/sample-request/3716
Major Players Analysis Listed in this Report are:
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Pacific Biosciences of California, Inc.
- Bio-Rad Laboratories
- QIAGEN
- Agilent Technologies
- PerkinElmer, Inc.
- ProPhase Labs, Inc. (Nebula Genomics)
- Novartis
- Psomagen
- Azenta Inc.
- Other Players
Antibody Production Market Report Scope:
| Report Attributes | Details |
| Market Size in 2023 | US$ 14.33 Billion |
| Market Size by 2032 | US$ 36.49 Billion |
| CAGR | CAGR of 10.95% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Regional Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Key Growth Drivers | • Growing chronic disease along with an increasing elderly population |
Novelties in Antibody Treatment Are all about Growth Needs, While Chronic Health Ills Trend Higher
The rising rates of chronic diseases like cancer and autoimmune diseases demonstrate the need for special therapies. Specifically, complex conditions require ideas such as the role of antibodies as an important foundation in the treatment of these diseases. It is characterized with high specificity and efficiency. Furthermore, the improvements in biotechnology such as in recombinant DNA technology and high through put screening has boosted the process of producing antibodies. This equally reduces costs and increases speed to market.
Do you have any specific queries or need any customization research on Antibody Production Market, Make an Enquiry Now@ https://www.snsinsider.com/enquiry/3716
The changing trends in the healthcare industry have helped in the expansion of the market due to such factors as the increased focus on personalized medicine. They can be acknowledged to patient-specific characteristics. Finally, treatment uses of antibodies are no longer limited to the initial ones that have initially introduced this category of drug. This generates new opportunities within the markets. Significant amounts of money are being spent in this regard towards research development. They contribute to find new antibody-based therapies. Thus, the increasing needs are being fulfilled by contract manufacturing organizations (CDMOs) that offer specialized services in antibody production. This helps companies invest in research and development areas that are complicated in manufacturing processes.
Antibody Production Market Key Segmentation:
By Product
- Instruments
- Bioreactors
- Multi-use Bioreactors
- Single-use Bioreactors
- Chromatography Systems
- Filtration systems
- Bioreactors
- Consumables
- Media
- Buffers and Reagents
- Chromatography Resins and Columns
- Filtration Consumables and Accessories
- Others
- Software
By Process
- Upstream Processing
- Downstream Processing
By Type
- Monoclonal Antibody
- Polyclonal Antibody
By End User
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
- CROs and CDMOs
Consumables Lead with 56% Share, Downstream Processing Dominates with 67.2% and Monoclonal Antibodies Excel in 2023
The consumables segment had the highest market share that was 56% by product. Consumables are, therefore, a broad category of products used in making of antibodies in other production processes. Such as reagent kits, media and buffer and many other related products.
By process, downstream processing segment dominated the market with a share of 67.2% in 2023. And is also expected to grow with fastest compound annual growth rate during the forecasted period. The process plays a role of checking the quality of the antibody. It also plays a safety, efficacy, purity and identification roles.
North America Leads Antibody Production Market in 2023 Driven by Biopharmaceutical Growth and Advanced Technological Investments
North America is considered a large market that also showed constant growth with CAGR of 38. 5% in 2023 because the United States and Canada with their large number of major biopharmaceutical companies and biotechnological companies are included in this region. Growing spending on medications and research to help drive the expansion of the market. Healthcare system also matters Capacities here, and readiness of health facilities also matters here. Biopharmaceutical products in North America are taking root and increasing the need for antibody production. Biopharmaceuticals, especially antibodies are gaining popularity because they are specific, effective, safer products. Three, they are applied in managing of different disorders.
Buy a Single-User PDF of Antibody Production Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/3716
Table of Contents – Major Key Points
1. Introduction
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Porter’s 5 Forces Model
6. Pest Analysis
7. Antibody Production Market Segmentation, by Product
8. Antibody Production Market Segmentation, by Process
9. Antibody Production Market Segmentation, by Type
10. Antibody Production Market Segmentation, by End-user
11. Regional Analysis
12. Company Profiles
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
Access Complete Report Details of Antibody Production Market Analysis & Outlook 2024-2032@ https://www.snsinsider.com/reports/antibody-production-market-3716
[For more information or need any customization research mail us at info@snsinsider.com]
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
